Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.05%
1,061.91
-0.49
-0.05%
—1,062.401,064.141,071.991,061.76——
SIXC
Communications
SIXC
Communications
SIXC
-0.32%
604.82
-1.92
-0.32%
—606.74606.74609.84604.58——
SIXE
Energy
SIXE
Energy
SIXE
+0.36%
1,242.61
+4.40
+0.36%
—1,238.211,236.601,246.411,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.53%
1,727.76
+9.15
+0.53%
—1,718.611,723.231,731.781,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.37%
639.72
+2.35
+0.37%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
-0.14%
852.40
-1.19
-0.14%
—853.59854.05858.19852.22——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.26%
217.77
-0.56
-0.26%
—218.33218.33219.73217.77——
SIXT
Technology
SIXT
Technology
SIXT
+1.26%
3,640.21
+45.40
+1.26%
—3,594.813,620.103,649.313,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.11%
909.56
+1.02
+0.11%
—908.54909.50914.66907.96——
SIXV
Health care
SIXV
Health care
SIXV
+1.04%
1,510.58
+15.58
+1.04%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.51%
2,410.64
+12.33
+0.51%
—2,398.312,406.822,417.092,405.28——
COH:ASX
Cochlear Ltd
A$97.53
+0.66%
(+0.64) 1D
May 22, 4:10:06 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for COH...
Open
A$97.03
High
A$98.66
Low
A$96.73
Mkt. cap
6.38B
Avg. vol.
807.01K
Volume
341.29K
Dividend
4.41%
Quarterly dividend
A$1.08
Ex-dividend date
Mar 20, 2025
P/E ratio
18.52
52-wk high
A$319.56
52-wk low
A$88.74
EPS
A$5.27
Shares outstanding
65.40M
No. of employees
6K
News stories
From sources across the web
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5.5K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitecochlear.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
585.65M
585.65M
583.60M
583.60M
Cost of goods sold
158.85M
158.85M
159.60M
159.60M
Cost of revenue
158.85M
158.85M
159.60M
159.60M
Research and development expenses
73.55M
73.55M
76.40M
76.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
234.95M
234.95M
224.70M
224.70M
Operating expense
301.25M
301.25M
297.85M
297.85M
Total operating expenses
460.10M
460.10M
457.45M
457.45M
Operating income
125.55M
125.55M
126.15M
126.15M
Other non operating income
-
-
-
-
EBT including unusual items
121.10M
121.10M
106.55M
106.55M
EBT excluding unusual items
122.40M
122.40M
128.25M
128.25M
Income tax expense
29.20M
29.20M
25.80M
25.80M
Effective tax rate
24.11%
24.11%
24.21%
24.21%
Other operating expenses
-7.25M
-7.25M
-3.25M
-3.25M
Net income
91.90M
91.90M
80.75M
80.75M
Net profit margin
15.69%
15.69%
13.84%
13.84%
Earnings per share
-
-
-
-
Interest and investment income
2.15M
2.15M
4.20M
4.20M
Interest expense
-2.65M
-2.65M
-3.15M
-3.15M
Net interest expenses
-500.00K
-500.00K
1.05M
1.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
129.05M
129.05M
151.95M
151.95M
Gain or loss from assets sale
-50.00K
-50.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer